Clinical evaluation of a new fractional ablative 2910 nm erbium laser on photodamaged skin: A pilot study
Lasers in Surgery and Medicine · 2023
DOI: 10.1002/lsm.23714 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lasers in Surgery and Medicine, 2023. Verfasst von Mona M Selim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Zel Skin and Laser Specialists, Edina, Minnesota, USA. Hauptthemen laut MEDLINE: Skin Aging, Lasers, Solid-State, Laser Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To examine the efficacy and safety of a new fractional, ablative erbium:glass fiber (Er:glass) laser (2910 nm) at improving clinical signs of photodamaged skin. Materials and Methods Thirty‐seven healthy participants aged 38–75 years with photodamaged skin were enrolled into two treatment groups. Group A ( n = 14) received up to four laser treatments with mild settings, and focal facial subunits were treated with deeper settings. Group B ( n = 23) received a single treatment using deeper settings. Following treatment, pain scores and severity and duration of skin responses (erythema, edema, and pinpoint bleeding) were assessed. Primary outcome was the improvement in participant and investigator Global Aesthetic Improvement Scale (GAIS) at 3‐month follow‐up. Secondary outcomes were participant satisfaction with treatment and whether they would repeat treatment.
Results
Thirty‐five participants completed the study ( n = 1 lost to follow up in each group). Both groups had similar mean participant and investigator GAIS scores of 3/5 corresponding to “Improvement.” All but two patients (both from Group A) reported improvement, satisfaction with treatment, and would repeat treatment. Posttreatment skin responses were mild‐to‐moderate, lasting up to 5 days. There was no scarring or dyspigmentation.
Conclusion
The 2910 nm Er:glass laser provided improvement in photoaging with high patient satisfaction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zel Skin and Laser Specialists, Edina, Minnesota, USA.
- Argo Research, Cape Coral, Florida, USA.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Mona M Selim
Zitieren
APA
Selim, M. M., Lowery, J. A., Maredia, H. S., & Zelickson, B. D. (2023). Clinical evaluation of a new fractional ablative 2910 nm erbium laser on photodamaged skin: A pilot study. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23714
Vancouver
Selim MM, Lowery JA, Maredia HS, Zelickson BD. Clinical evaluation of a new fractional ablative 2910 nm erbium laser on photodamaged skin: A pilot study. Lasers in Surgery and Medicine. 2023. doi:10.1002/lsm.23714
BibTeX
@article{Selim2023,
author = {Selim, Mona M and Lowery, Joseph A and Maredia, Hasina S and Zelickson, Brian D},
title = {Clinical evaluation of a new fractional ablative 2910 nm erbium laser on photodamaged skin: A pilot study},
journal = {Lasers in Surgery and Medicine},
year = {2023},
doi = {10.1002/lsm.23714}
}
EUVIMED